Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

A Chemically Modified Curcumin (CMC 2.24) Inhibits Nuclear Factor kappa B Activation and Inflammatory Bone Loss in Murine Models of LPS-Induced Experimental Periodontitis and Diabetes-Associated Natural Periodontitis

Full text
Author(s):
Elburki, Muna S. ; Rossa, Jr., Carlos ; Guimares-Stabili, Morgana R. ; Lee, Hsi-Ming ; Curylofo-Zotti, Fabiana A. ; Johnson, Francis ; Golub, Lorne M.
Total Authors: 7
Document type: Journal article
Source: Inflammation; v. 40, n. 4, p. 1436-1449, AUG 2017.
Web of Science Citations: 9
Abstract

The purpose of this study was to assess the effect of a novel chemically modified curcumin (CMC 2.24) on NF-kappa B and MAPK signaling and inflammatory cytokine production in two experimental models of periodontal disease in rats. Experimental model I: Periodontitis was induced by repeated injections of LPS into the gingiva (3x/week, 3 weeks); control rats received vehicle injections. CMC 2.24, or the vehicle, was administered by daily oral gavage for 4 weeks. Experimental model II: Diabetes was induced in adult male rats by streptozotocin injection; periodontal breakdown then results as a complication of uncontrolled hyperglycemia. Non-diabetic rats served as controls. CMC 2.24, or the vehicle, was administered by oral gavage daily for 3 weeks to the diabetics. Hemimaxillae and gingival tissues were harvested, and bone loss was assessed radiographically. Gingival tissues were pooled according to the experimental conditions and processed for the analysis of matrix metalloproteinases (MMPs) and bone-resorptive cytokines. Activation of p38 MAPK and NF-kappa B signaling pathways was assessed by western blot. Both LPS and diabetes induced an inflammatory process in the gingival tissues associated with excessive alveolar bone resorption and increased activation of p65 (NF-kappa B) and p38 MAPK. In both models, the administration of CMC 2.24 produced a marked reduction of inflammatory cytokines and MMPs in the gingival tissues, decreased bone loss, and decreased activation of p65 (NF-kappa B) and p38 MAPK. Inhibition of these cell signaling pathways by this novel tri-ketonic curcuminoid (natural curcumin is di-ketonic) may play a role in its therapeutic efficacy in locally and systemically associated periodontitis. (AU)

FAPESP's process: 10/19660-2 - Biological mechanisms of curcumin-mediated modulation of osteoclastogenesis, bone resorption and repair
Grantee:Morgana Rodrigues Guimarães Stabili
Support type: Scholarships in Brazil - Post-Doctorate
FAPESP's process: 10/20091-2 - Biological mechanisms of curcumin-mediated modulation of osteoclastogenesis, bone resorption and repair
Grantee:Carlos Rossa Junior
Support type: Regular Research Grants
FAPESP's process: 09/54080-0 - Acquisition of an in vivo microtomography scanner for use in the Laboratory for Characterization and Evaluation of Biological Responses
Grantee:Elcio Marcantonio Junior
Support type: Multi-user Equipment Program
FAPESP's process: 12/15826-9 - Modulation of inflammatory bone resorption by a novel chemically modified curcumin. Focus on osteoclastogenesis.
Grantee:Fabiana Almeida Curylofo Zotti
Support type: Scholarships in Brazil - Master